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TECHNICAL ADVANCE
The German Corona Consensus Dataset 
(GECCO): a standardized dataset for COVID-19 
research in university medicine and beyond
Julian Sass1 , Alexander Bartschke2, Moritz Lehne1 , Andrea Essenwanger1 , Eugenia Rinaldi2, 
Stefanie Rudolph2 , Kai U. Heitmann3, Jörg J. Vehreschild4,5,6 , Christof von Kalle1,2  and Sylvia Thun1,2,7* 
Abstract 
Background: The current COVID-19 pandemic has led to a surge of research activity. While this research provides 
important insights, the multitude of studies results in an increasing fragmentation of information. To ensure compara-
bility across projects and institutions, standard datasets are needed. Here, we introduce the “German Corona Con-
sensus Dataset” (GECCO), a uniform dataset that uses international terminologies and health IT standards to improve 
interoperability of COVID-19 data, in particular for university medicine.
Methods: Based on previous work (e.g., the ISARIC-WHO COVID-19 case report form) and in coordination with 
experts from university hospitals, professional associations and research initiatives, data elements relevant for COVID-
19 research were collected, prioritized and consolidated into a compact core dataset. The dataset was mapped to 
international terminologies, and the Fast Healthcare Interoperability Resources (FHIR) standard was used to define 
interoperable, machine-readable data formats.
Results: A core dataset consisting of 81 data elements with 281 response options was defined, including information 
about, for example, demography, medical history, symptoms, therapy, medications or laboratory values of COVID-19 
patients. Data elements and response options were mapped to SNOMED CT, LOINC, UCUM, ICD-10-GM and ATC, and 
FHIR profiles for interoperable data exchange were defined.
Conclusion: GECCO provides a compact, interoperable dataset that can help to make COVID-19 research data more 
comparable across studies and institutions. The dataset will be further refined in the future by adding domain-specific 
extension modules for more specialized use cases.
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Background
In December 2019, first reports of a cluster of 41 patients 
infected by a novel coronavirus emerged from Wuhan, 
China [1]. Within a few months, the new virus, subse‑
quently named “severe acute respiratory syndrome coro‑
navirus 2” (SARS‑CoV‑2), has spread around the world 
causing the global COVID‑19 pandemic. Currently (as 
of November 12, 2020), SARS‑CoV‑2 has infected more 
than 50 million and killed more than a million patients 
worldwide [2].
The pandemic has spurred intensive scientific research, 
including numerous regional, national and international 
epidemiological surveys and studies [3–7]. While this 
research provides important new insights, the multitude 
of studies threatens to generate a dangerous fragmenta‑
tion of information. This could delay or even prevent 
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urgently needed scientific knowledge about SARS‑CoV‑2 
and COVID‑19. To avoid this fragmentation of informa‑
tion and make COVID‑19 data more comparable and 
exchangeable across studies and institutions, interoper‑
able datasets are needed.
Various initiatives have started to define uniform data‑
sets and Common Data Elements (CDEs) for the col‑
lection of information about COVID‑19. For example, 
questionnaires and case report forms (CRFs) have been 
developed to collect data about COVID‑19 patients in 
a standardized way [5, 8, 9]. While the CDEs defined in 
these projects are an important step, they are not enough 
to ensure interoperability. To make data syntactically 
and semantically interoperable, data elements have to 
be embedded in standard data structures that can be 
exchanged across IT systems; they also have to use com‑
mon terminologies that unambiguously define the mean‑
ing of clinical concepts.
To improve interoperability of COVID‑19 data, we 
developed the German Corona Consensus Dataset 
(GECCO), which uses international health IT stand‑
ards and terminologies for interoperable data exchange. 
GECCO defines a compact set of data elements to be col‑
lected in COVID‑19 studies and was developed within 
the German COVID‑19 Research Network of University 
Medicine (“Netzwerk Universitätsmedizin”) funded by 
the German Federal Ministry of Education and Research 
(BMBF) [10]. This article provides an overview of the 
GECCO dataset and its development.
Methods
Selection of data elements
An initial dataset was compiled as a working basis by 
merging data elements and response options of the 
following projects: the ISARIC‑WHO CRF [8]; the 
Pa‑COVID‑19 study [11], which investigates the patho‑
physiology of COVID‑19 in a prospective patient cohort; 
the LEOSS case registry [3], a clinical patient registry 
for patients infected with SARS‑CoV‑2 initiated by the 
ESCMID Emerging Infections Task Force (EITaF), the 
German Center for Infection Research (DZIF) and the 
German Society for Infectiology (DGI). This draft data‑
set was saved in a spreadsheet and sent to members of 
an expert board for comment and proposal of additional 
data elements. The expert board was composed of health 
professionals from 50 institutions, in particular depart‑
ments from German university hospitals, professional 
associations and other relevant organizations (such as the 
Medical Informatics Initiative [12] or the National Asso‑
ciation of Statutory Health Insurance Physicians [13]). 
New data elements proposed by the expert board were 
added to the dataset for subsequent prioritization. For 
the prioritization, the experts were asked to assign a pri‑
ority value to each data element of the dataset. Priorities 
were indicated on a 5‑level scale that was loosely based 
on the NIH model for CDEs [14] (Table 1).
From the data elements with the highest prioritiza‑
tions, a preliminary core dataset with roughly 100 data 
elements was compiled (this size was chosen to include 
as many relevant data elements as possible, while keep‑
ing the dataset manageable and practical). This core 
dataset was then reviewed by an editorial team of seven 
experts from different disciplines. In consensual deci‑
sions, data elements not considered necessary for the 
core dataset were discarded (note that these data ele‑
ments were retained for additional extension modules, 
see Results); conversely, data elements that were consid‑
ered highly important but had not yet been included in 
the core dataset were added. The final data elements of 
the core dataset were grouped into meaningful categories 
(e.g., demographics, symptoms or medication). Figure  1 
shows the workflow of consensus building and dataset 
definition.
Standardization
To ensure syntactic and semantic interoperability, ele‑
ments and response options of the core dataset were 
mapped to international standards and terminologies. 
Table 1 Prioritization of data elements
* Since this is a disease-specific (i.e. COVID-19) dataset, both the general and disease-specific core categories of the NIH were assigned to the highest priority level
Scale value Priority NIH classification Definition
5 Highly relevant General core/disease core* Data element with essential general or specific information relevant to COVID-
19
4 Very relevant Supplemental—highly recommended Data element that is essential under certain conditions or for certain study 
types and is therefore strongly recommended
3 Relevant Supplemental Data element that is often collected in clinical studies, but whose relevance 
depends on the study design or type of research
2 Less relevant Exploratory Data element that requires further validation, but which can fill current gaps in 
the data elements and/or replace an existing data element
1 Not relevant – Data elements that are not considered relevant to the dataset
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The following terminologies and code systems were used: 
the International Statistical Classification of Diseases and 
Related Health Problems, 10th revision, German modifi‑
cation (ICD‑10‑GM) [15] for diagnoses; Logical Obser‑
vation Identifiers Names and Codes (LOINC) [16] for 
laboratory values and other measurements; the Unified 
Code for Units of Measure (UCUM) [17] for measure‑
ment units; the Anatomical Therapeutic Chemical Clas‑
sification System (ATC) [18] for active ingredients of 
drugs and medications; SNOMED CT [19] for diagnoses 
and other medical concepts. We used two terminology 
systems—SNOMED CT and ICD‑10‑GM—for diagno‑
ses because ICD‑10‑GM is the dominant classification 
system in German healthcare and is important for reim‑
bursement purposes, whereas SNOMED CT allows for 
a more detailed coding of clinical terms and is therefore 
preferable for better medical accuracy. The annotation of 
data elements with international terminologies was done 
using ART‑DECOR [20], an open source collaboration 
platform for experts from medical, terminological and 
technical domains aiming on creation and maintenance 
of datasets with data element descriptions, use case sce‑
narios, value sets and Health Level 7 (HL7) templates and 
profiles.
To define interoperable formats for data exchange, 
the HL7 standard "Fast Healthcare Interoperability 
Resources" (FHIR) [21] was used. FHIR builds on a set 
of “resources”, which provide generic data structures 
for common healthcare concepts, such as Patient, Prac‑
titioner, Observation, Medication or Condition. From 
these resources more specific data structure definitions, 
so‑called “profiles”, can be defined, which allow for inter‑
operable data exchange across health IT systems. To 
ensure interoperability, care was taken to build on previ‑
ous work where possible, in particular the FHIR profiles 
of the German Medical Informatics Initiative [22], the 
International Patient Summary (IPS) [23], the Logica 
COVID‑19 profiles [24] and the FHIR base profiles of 
HL7 Germany [25]. FHIR profiles were defined using 
Forge [26] and published on the Simplifier platform [27].
Results
Combining the initial draft dataset and the additional 
proposals from the expert board, 702 potentially relevant 
data elements were collected. From these data elements 
and based on the prioritization of the expert board, the 
editorial team compiled a core dataset consisting of 81 
elements with 281 response options. These data elements 
were grouped into the following categories: anamne‑
sis/risk factors (n = 16); imaging (n = 2); demographics 
(n = 7); epidemiological factors (n = 1); complications 
(n = 1); onset of illness/admission (n = 1); laboratory val‑
ues (n = 25); medication (n = 4); outcome at discharge 
(n = 3); study enrollment/inclusion criteria (n = 2); symp‑
toms (n = 2); therapy (n = 6); vital signs (n = 11) (Fig. 2).
For all data elements and their corresponding response 
options, value sets were created using codes from 
SNOMED CT, LOINC, UCUM, ICD‑10‑GM and ATC. 
Data elements, response options and associated value 
Fig. 1 Workflow of consensus building and definition of data elements for the GECCO dataset
Page 4 of 7Sass et al. BMC Med Inform Decis Mak          (2020) 20:341 
sets of the GECCO dataset can be accessed on the ART‑
DECOR platform [28].
Subsequently, FHIR profiles were created for the data 
elements. The following FHIR resources were used to 
model the data elements: Patient, Consent, Observation, 
Condition, Procedure, Encounter, Medication and Medi‑
cationStatement. The FHIR profiles can be accessed on 
Simplifier [29].
During the consolidation process, it became clear 
that some data elements are important for certain disci‑
plines but irrelevant for others. These elements were not 
included in the GECCO core dataset as they would have 
inflated the size of the dataset. The editorial team decided 
to include these data elements in domain‑specific exten‑
sion modules, which will be specified in more detail at 
later stages of the project.
Discussion
In this report, we presented the GECCO dataset, a core 
collection of data elements for acquiring and exchanging 
information about COVID‑19 patients. By using stand‑
ardized data structures (HL7 FHIR profiles) and interna‑
tional terminologies, the GECCO dataset is an important 
step towards interoperability of COVID‑19 research data. 
It can facilitate harmonized data collection and analysis 
Fig. 2 GECCO dataset categories into which data elements were grouped
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across institutions and IT systems, for example in clinical 
studies, registries or digital health applications.
A key factor to the successful application of stand‑
ard datasets like GECCO is a close collaboration with 
the scientific community. To ensure a high acceptance 
of the dataset, the development of GECCO therefore 
included clinicians from a wide variety of medical disci‑
plines and professional associations as well as experts in 
digital health, standardization and clinical terminologies. 
GECCO also collaborates closely with standards devel‑
oping organizations such as HL7 and Integrating the 
Healthcare Enterprise (IHE) as well as other initiatives 
aiming to improve health data interoperability, such as 
the Medical Informatics Initiative [12], NFDI4Health [30] 
and the Corona Component Standards (cocos) [31].
For the successful application of standard datasets 
like GECCO, it is also important that these datasets are 
embedded in larger infrastructures for secure and inter‑
operable data sharing across institutions. Initiatives like, 
for example, the National COVID Cohort Collaborative 
(N3C) in the US [32], OpenSAFELY in the UK [33] or the 
international project Secure Collective Research (SCOR) 
[34] are developing platforms for a secure, cross‑institu‑
tional analysis of COVID‑19 data. Similarly, GECCO is 
part of the German COVID‑19 Research Network of Uni‑
versity Medicine [10], which aims to bundle the resources 
of German university hospitals to improve diagnostics 
and treatment of COVID‑19 patients. The network also 
includes a research data infrastructure for the secure and 
interoperable data exchange across university hospitals 
[35], for which GECCO provides a standard data struc‑
ture. For example, projects such as NAPKON, a national 
project for collecting research data during pandemics 
[36], will collect their data according to the specifications 
of the GECCO dataset.
Note that the GECCO dataset was originally developed 
for German university medicine. However, we used inter‑
national standards and terminologies to ensure that the 
GECCO dataset can be extended to use cases beyond 
university medicine and also be applied in international 
contexts. When defining the FHIR profiles, we also took 
into account international work (for example the IPS 
[23]) to make sure that the GECCO dataset can provide 
interoperability when used internationally.
Although the GECCO dataset was designed to be as 
compact and manageable as possible, acquiring and 
recording the information for all data elements still 
requires time (for example, when entering the infor‑
mation in an electronic case report form). Moreover, 
manual documentation is prone to transcription errors. 
Conversely, manually abstracted and structured infor‑
mation from unstructured health records may provide 
relevant insights for care‑providers and improve their 
understanding of risk and outcome. For some of the data 
items, it is therefore desirable to automatically exchange 
data between a GECCO‑based study database and exist‑
ing IT systems, such as hospital information systems or 
clinical trial software. This requires standard interfaces 
between these systems. The FHIR profiles of the GECCO 
dataset provide an interoperable, machine‑readable data 
structure that can facilitate this data exchange across IT 
systems. For example, LOINC‑coded information about 
patients’ laboratory values could be directly transferred 
from the hospital information system to the GECCO 
dataset. For electronic data capture (EDC) systems used 
in clinical studies, converters are currently being devel‑
oped that transform the underlying software formats into 
the GECCO HL7 FHIR format for interoperable data 
exchange. Independently of the work presented here, the 
GECCO dataset has also been converted to the CDISC 
Operational Data Model (ODM) and is published on the 
Portal of Medical Data Models (MDM) of the University 
of Münster [37].
The aim of the GECCO dataset was to define a com‑
pact set of core data elements for which most COVID‑
19 studies (particularly the studies conducted at German 
university hospitals) can provide full information. How‑
ever, if not explicitly required, studies that want to use the 
GECCO dataset may use subsets of the dataset if they are 
unable to provide full information for all data elements.
Scientific knowledge about COVID‑19 and SARS‑
CoV‑2 is changing fast, which may necessitate modifica‑
tions to the GECCO dataset in the future. Furthermore, 
the use of the GECCO dataset in clinical research pro‑
jects will provide practical experience that may also 
motivate changes to the dataset. To incorporate new 
knowledge into the dataset, the COVID‑19 Research 
Network of University Medicine [10] will put a govern‑
ance framework in place that will coordinate revisions 
and extensions to the dataset. Domain‑specific extension 
modules are already in preparation, which include many 
of the data elements that were not considered essen‑
tial for the core dataset. Extension modules currently 
planned are: laboratory, diagnostics, immunology, gyne‑
cology and pregnancy, epidemiology, pediatrics, intensive 
care, oncology, radiology, virology, psychiatry and neu‑
rology (these extension modules are also made accessible 
on the ART‑DECOR platform [38]).
Conclusion
The GECCO dataset provides researchers and health‑
care professionals with a compact, interoperable data‑
set for collecting, exchanging and analyzing COVID‑19 
data across institutions and software systems. Developed 
by a multidisciplinary group of experts, GECCO builds 
heavily on international terminologies and IT standards. 
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GECCO can thus help to improve the harmonization and 
coordination of research efforts to successfully fight the 
COVID‑19 pandemic. Future inclusion of domain‑spe‑
cific extension modules will further expand the use of the 
GECCO dataset.
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